Azienda Ospedaliera S. Maria

Terni 05100

0 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumor, Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients., Breast Cancer, Lymphoma, T-Cell, Peripheral, Metastatic Solid Tumors, Renal Cell Carcinoma

Studies at this site

• A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01) — Running, not enrolling
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma — Completed
• Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects — Completed
• Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication — Completed